Did you know that HER2-targeted therapy is an established
treatment option for patients with HER2-positive metastatic
gastric/gastroesophageal junction (GEJ) cancer?
Credit available for this activity expires: 4/16/25
Earn Credit / Learning Objectives & Disclosures:
Did you know that HER2-targeted therapy is an established
treatment option for patients with HER2-positive metastatic
gastric/gastroesophageal junction (GEJ) cancer?
Credit available for this activity expires: 3/29/25
Earn Credit / Learning Objectives & Disclosures:
Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.